LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 47.93 | 27.76 | 5450 | 4421 | 1.2326 | 1.0580 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 49.63 | 27.76 | 344 | 4818 | 0.0714 | 0.4026 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 49.63 | 27.76 | 6003 | 4818 | 1.2459 | 1.0600 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 49.63 | 27.76 | 5765 | 4818 | 1.1965 | 1.0488 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 49.63 | 27.76 | 5833 | 4818 | 1.2107 | 1.0521 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 51.33 | 27.76 | 360 | 5117 | 0.0704 | 0.4056 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 51.33 | 27.76 | 6400 | 5117 | 1.2507 | 1.0603 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 51.33 | 27.76 | 6080 | 5117 | 1.1882 | 1.0463 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 51.33 | 27.76 | 6145 | 5117 | 1.2009 | 1.0492 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 53.04 | 27.76 | 436 | 5365 | 0.0813 | 0.4371 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 53.04 | 27.76 | 6702 | 5365 | 1.2490 | 1.0594 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 53.04 | 27.76 | 6373 | 5365 | 1.1877 | 1.0458 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 53.04 | 27.76 | 6475 | 5365 | 1.2067 | 1.0501 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 54.74 | 27.76 | 461 | 5606 | 0.0822 | 0.4433 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 54.74 | 27.76 | 7111 | 5606 | 1.2683 | 1.0631 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 54.74 | 27.76 | 6705 | 5606 | 1.1959 | 1.0473 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 54.74 | 27.76 | 6809 | 5606 | 1.2145 | 1.0514 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 56.45 | 27.76 | 602 | 5745 | 0.1048 | 0.4917 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 56.45 | 27.76 | 7573 | 5745 | 1.3181 | 1.0731 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 56.45 | 27.76 | 7125 | 5745 | 1.2401 | 1.0567 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 56.45 | 27.76 | 7223 | 5745 | 1.2572 | 1.0604 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 58.15 | 27.76 | 584 | 5906 | 0.0989 | 0.4828 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 58.15 | 27.76 | 7971 | 5906 | 1.3495 | 1.0790 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 58.15 | 27.76 | 7336 | 5906 | 1.2420 | 1.0568 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 58.15 | 27.76 | 7475 | 5906 | 1.2655 | 1.0618 | MN20160318_Q01 | L07 |